The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tolerability and outcomes with serial cycles of 28 days of venetoclax in newly diagnosed patients with AML.
 
Jesse Sanchez
No Relationships to Disclose
 
Michael Jones
No Relationships to Disclose
 
Katie Julian
No Relationships to Disclose
 
Megan Connor
No Relationships to Disclose
 
Rebecca Rezac
No Relationships to Disclose
 
Kelsey Marciano
No Relationships to Disclose
 
Katelyn Anttila
No Relationships to Disclose
 
Connor Sohalski
No Relationships to Disclose
 
Ayele Belachew
No Relationships to Disclose
 
Matthew Angelos
No Relationships to Disclose
 
Christine McMahon
Consulting or Advisory Role - Kura Oncology; Syndax
Research Funding - Syndax (Inst); Syros Pharmaceuticals (Inst)
 
Andrew Kent
No Relationships to Disclose
 
Maria Amaya
No Relationships to Disclose
 
Marc Schwartz
Consulting or Advisory Role - Autolus; Kite, a Gilead company
 
Jonathan Gutman
No Relationships to Disclose
 
Daniel Pollyea
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Gilead Sciences; Karyopharm Therapeutics; MEI Pharma; OncoVerity; Qihan Biotech; Rigel; Ryvu Therapeutics; Sanofi; Seres Therapeutics; Servier; Syndax
Research Funding - Abbvie; Bristol Myers Squibb Foundation; Karyopharm Therapeutics; Teva